CC BY-NC-ND 4.0 · Journal of Child Science 2020; 10(01): e104-e109
DOI: 10.1055/s-0040-1716713
Review Article

Possible Protective Role of Melatonin in Pediatric Infectious Diseases and Neurodevelopmental Pathologies

Antonio Molina-Carballo
1   Department of Pediatrics, Unit of Pediatric Neurology and Neurodevelopment, Clínico San Cecilio University Hospital, the Andalusian Health Service, School of Medicine, University of Granada, Granada, Spain
,
Antonio Emilio Jerez-Calero
1   Department of Pediatrics, Unit of Pediatric Neurology and Neurodevelopment, Clínico San Cecilio University Hospital, the Andalusian Health Service, School of Medicine, University of Granada, Granada, Spain
,
Antonio Muñoz-Hoyos
1   Department of Pediatrics, Unit of Pediatric Neurology and Neurodevelopment, Clínico San Cecilio University Hospital, the Andalusian Health Service, School of Medicine, University of Granada, Granada, Spain
› Author Affiliations

Abstract

Melatonin, produced in every cell that possesses mitochondria, acts as an endogenous free radical scavenger, and improves energetic metabolism and immune function, by complex molecular crosstalk with other intracellular compounds. There is greatly increasing evidence regarding beneficial effects of acute and chronic administration of high melatonin doses, in infectious, developmental, and degenerative pathologies, as an endothelial cell and every cell protectant.



Publication History

Received: 06 June 2020

Accepted: 07 August 2020

Article published online:
23 September 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Suofu Y, Li W, Jean-Alphonse FG. et al Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release. Proc Natl Acad Sci USA 2017; 114 (38) E7997-E8006
  • 2 Zhao D, Yu Y, Shen Y. et al Melatonin synthesis and function: evolutionary history in animals and plants. Front Endocrinol (Lausanne) 2019; 10: 249-249
  • 3 Shneider A, Kudriavtsev A, Vakhrusheva A. Can melatonin reduce the severity of COVID-19 pandemic?. Int Rev Immunol 2020; 39 (04) 153-162
  • 4 Reiter RJ, Ma Q, Sharma R. Treatment of Ebola and other infectious diseases: melatonin “goes viral.”. Melatonin Res 2020; 3: 43-57
  • 5 Chen ZM, Fu JF, Shu Q. et al Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr 2020; 16 (03) 240-246
  • 6 Li M, Chen L, Zhang J, Xiong C, Li X. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One 2020; 15 (04) e0230295
  • 7 Varga Z, Flammer AJ, Steiger P. et al Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395 (10234): 1417-1418
  • 8 Zhou P, Yang X-L, Wang X-G. et al A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579 (7798): 270-273
  • 9 Kuba K, Imai Y, Rao S. et al A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005; 11 (08) 875-879
  • 10 Kai H, Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Hypertens Res 2020; 43 (07) 648-654
  • 11 Jarcho JA, Ingelfinger JR, Hamel MB, D'Agostino Sr RB, Harrington DP. Inhibitors of the renin-angiotensin-aldosterone system and Covid-19. N Engl J Med 2020; 382 (25) 2462-2464
  • 12 Hobson SR, Gurusinghe S, Lim R. et al Melatonin improves endothelial function in vitro and prolongs pregnancy in women with early-onset preeclampsia. J Pineal Res 2018; 65 (03) e12508
  • 13 Anderson G, Reiter RJ. Melatonin: roles in influenza, Covid-19, and other viral infections. Rev Med Virol 2020; 30 (03) e2109
  • 14 Cardinali DP. Are melatonin doses employed clinically adequate for melatonin-induced cytoprotection?. Melatonin Res 2019; 2: 106-132
  • 15 Tan DX, Reiter RJ. Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells. Melatonin Res 2019; 2: 44-66
  • 16 Xin Z, Zhang X, Hu W. et al The protective effects of melatonin on organisms against the environmental pollutants of heavy metal and non-mental toxins. Melatonin Res 2019; 2: 99-120
  • 17 Carrillo-Vico A, Lardone PJ, Alvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero JM. Melatonin: buffering the immune system. Int J Mol Sci 2013; 14 (04) 8638-8683
  • 18 Banerjee A, Czinn SJ, Reiter RJ, Blanchard TG. Crosstalk between endoplasmic reticulum stress and anti-viral activities: a novel therapeutic target for COVID-19. Life Sci 2020; 255: 117842
  • 19 Hastings MH, Maywood ES, Brancaccio M. The mammalian circadian timing system and the suprachiasmatic nucleus as its pacemaker. Biology (Basel) 2019; 8 (01) E13
  • 20 Logan RW, McClung CA. Rhythms of life: circadian disruption and brain disorders across the lifespan. Nat Rev Neurosci 2019; 20 (01) 49-65
  • 21 Erren TC, Reiter RJ. Defining chronodisruption. J Pineal Res 2009; 46 (03) 245-247
  • 22 Acuña-Castroviejo D, Rahim I, Acuña-Fernández C. et al Melatonin, clock genes and mitochondria in sepsis. Cell Mol Life Sci 2017; 74 (21) 3965-3987
  • 23 Stone TW. Tryptophan and kynurenines: continuing to court controversy. Clin Sci (Lond) 2016; 130 (15) 1335-1337
  • 24 Reiter RJ, Tan DX, Rosales-Corral S, Galano A, Jou M-J, Acuna-Castroviejo D. Melatonin mitigates mitochondrial meltdown: interactions with SIRT3. Int J Mol Sci 2018; 19 (08) 24-39
  • 25 Ivanov DO, Evsyukova II, Mazzoccoli G. et al The role of prenatal melatonin in the regulation of childhood obesity. Biology (Basel) 2020; 9 (04) E72
  • 26 Notarangelo FM, Pocivavsek A. Elevated kynurenine pathway metabolism during neurodevelopment: implications for brain and behavior. Neuropharmacology 2017; 112 (Pt B): 275-285
  • 27 Julio-Pieper M, O'Connor RM, Dinan TG, Cryan JF. Regulation of the brain-gut axis by group III metabotropic glutamate receptors. Eur J Pharmacol 2013; 698 (1-3): 19-30
  • 28 Gao J, Xu K, Liu H. et al Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Microbiol 2018; 8: 13
  • 29 Erny D, Hrabě de Angelis AL, Jaitin D. et al Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 2015; 18 (07) 965-977
  • 30 Girchenko P, Lahti-Pulkkinen M, Heinonen K. et al Persistently high levels of maternal antenatal inflammation are associated with and mediate the effect of prenatal environmental adversities on neurodevelopmental delay in the offspring. Biol Psychiatry 2020; 87 (10) 898-907
  • 31 Frontera A, Martin C, Vlachos K, Sgubin G. Regional air pollution persistence links to COVID-19 infection zoning. J Infect 2020; 81 (02) 318-356
  • 32 Cheng Z, Huo X, Dai Y, Lu X, Hylkema MN, Xu X. Elevated expression of AhR and NLRP3 link polycyclic aromatic hydrocarbon exposure to cytokine storm in preschool children. Environ Int 2020; 139: 105720
  • 33 Moloudizargari M, Moradkhani F, Asghari N. et al NLRP inflammasome as a key role player in the pathogenesis of environmental toxicants. Life Sci 2019; 231: 116585
  • 34 Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, Tan DX. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 2009; 15 (1-2): 43-50
  • 35 Mortezaee K, Potes Y, Mirtavoos-Mahyari H. et al Boosting immune system against cancer by melatonin: a mechanistic viewpoint. Life Sci 2019; 238: 116960
  • 36 Tarocco A, Caroccia N, Morciano G. et al Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care. Cell Death Dis 2019; 10 (04) 317
  • 37 Cardinali DP. Melatonin: clinical perspectives in neurodegeneration. Front Endocrinol (Lausanne) 2019; 10: 480
  • 38 Pires-Lapa MA, Tamura EK, Salustiano EM, Markus RP. Melatonin synthesis in human colostrum mononuclear cells enhances dectin-1-mediated phagocytosis by mononuclear cells. J Pineal Res 2013; 55 (03) 240-246
  • 39 Esposito E, Cuzzocrea S. Antiinflammatory activity of melatonin in central nervous system. Curr Neuropharmacol 2010; 8 (03) 228-242
  • 40 Hardeland R. Aging, melatonin, and the pro- and anti-inflammatory networks. Int J Mol Sci 2019; 20 (05) E1223
  • 41 Cao Z, Fang Y, Lu Y. et al Melatonin alleviates cadmium-induced liver injury by inhibiting the TXNIP-NLRP3 inflammasome. J Pineal Res 2017; 62 (03) DOI: 10.1111/jpi.12389.
  • 42 Liu Z, Gan L, Xu Y. et al Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-κB/GSDMD signal in mice adipose tissue. J Pineal Res 2017; 63 (01) DOI: 10.1111/jpi.12414.
  • 43 Cardinali DP. An assessment of melatonin's therapeutic value in the hypoxic-ischemic encephalopathy of the newborn. Front Synaptic Neurosci 2019; 11: 34
  • 44 Silvestri M, Rossi GA. Melatonin: its possible role in the management of viral infections--a brief review. Ital J Pediatr 2013; 39: 61
  • 45 Muñoz-Hoyos A, Bonillo-Perales A, Avila-Villegas R. et al Melatonin levels during the first week of life and their relation with the antioxidant response in the perinatal period. Neonatology 2007; 92 (03) 209-216
  • 46 Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L. Melatonin as an antioxidant: under promises but over delivers. J Pineal Res 2016; 61 (03) 253-278
  • 47 Kornblihtt LI, Finocchiaro L, Molinas FC. Inhibitory effect of melatonin on platelet activation induced by collagen and arachidonic acid. J Pineal Res 1993; 14 (04) 184-191
  • 48 Venegas C, García JA, Escames G. et al Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2012; 52 (02) 217-227
  • 49 Fiorina P, Lattuada G, Ponari O, Silvestrini C, Dall’Aglio P. Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. Lancet 1996; 347 (9002): 692-693
  • 50 Fiorina P, Lattuada G, Silvestrini C, Ponari O, Dall'Aglio P. Disruption of nocturnal melatonin rhythm and immunological involvement in ischaemic stroke patients. Scand J Immunol 1999; 50 (02) 228-231
  • 51 Jerez-Calero A, Salvatierra-Cuenca MT, Benitez-Feliponi Á. et al Hypothermia plus melatonin in asphyctic newborns: a randomized-controlled pilot study. Pediatr Crit Care Med 2020; 21 (07) 647-655
  • 52 Reiter RJ, Sharma R, Ma Q, Dominquez-Rodriguez A, Marik PE, Abreu-Gonzalez P. Melatonin inhibits COVID-19-induced cytokine storm by reversing aerobic glycolysis in immune cells: a mechanistic analysis. Med Drug Discov 2020; 6: 100044
  • 53 Reiter RJ, Abreu-Gonzalez P, Marik PE, Dominguez-Rodriguez A. Therapeutic algorithm for use of melatonin in patients with COVID-19. Front Med (Lausanne) 2020; 7: 226
  • 54 García IG, Rodriguez-Rubio M, Mariblanca AR. et al A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): a structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21 (01) 466
  • 55 Carloni S, Proietti F, Rocchi M. et al Melatonin pharmacokinetics following oral administration in preterm neonates. Molecules 2017; 22 (12) E2115
  • 56 Gitto E, Karbownik M, Reiter RJ. et al Effects of melatonin treatment in septic newborns. Pediatr Res 2001; 50 (06) 756-760
  • 57 Wong SF, Chow KM, de Swiet M. Severe acute respiratory syndrome and pregnancy. BJOG 2003; 110 (07) 641-642
  • 58 Chen H, Guo J, Wang C. et al Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395 (10226): 809-815
  • 59 Donnelly JM, Lindsay K, Walsh JM. et al Perinatal inflammation and childhood adiposity - a gender effect?. J Matern Fetal Neonatal Med 2020; 33 (07) 1203-1210
  • 60 Li Y, Zheng Q, Zou L. et al Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition. Pediatr Rheumatol Online J 2019; 17 (01) 1
  • 61 Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J 2020; 39 (05) 355-368
  • 62 Baschat AA. Neurodevelopment after fetal growth restriction. Fetal Diagn Ther 2014; 36 (02) 136-142
  • 63 Motta-Teixeira LC, Machado-Nils AV, Battagello DS. et al The absence of maternal pineal melatonin rhythm during pregnancy and lactation impairs offspring physical growth, neurodevelopment, and behavior. Horm Behav 2018; 105: 146-156
  • 64 Palmer KR, Mockler JC, Davies-Tuck ML. et al Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction. BMJ Open 2019; 9 (06) e028243